Schröder FH - Search Results

1

The plication procedure for penile curvature: surgical outcome and postoperative sexual functioning.

van der Drift DG, Vroege JA, Groenendijk PM, Slob AK, Schröder FH, Mickisch GH. van der Drift DG, et al. Among authors: schroder fh. Urol Int. 2002;69(2):120-4. doi: 10.1159/000065560. Urol Int. 2002. PMID: 12187042

2

The artificial urinary sphincter in men incontinent after radical prostatectomy: 5 year actuarial adequate function rates.

Klijn AJ, Hop WC, Mickisch G, Schröder FH, Bosch JL. Klijn AJ, et al. Among authors: schroder fh. Br J Urol. 1998 Oct;82(4):530-3. doi: 10.1046/j.1464-410x.1998.00807.x. Br J Urol. 1998. PMID: 9806182

3

Spontaneous remission of a bony metastasis in prostatic adenocarcinoma.

Schurmans JR, Blijenberg BG, Mickisch GH, Schröder FH. Schurmans JR, et al. Among authors: schroder fh. J Urol. 1996 Feb;155(2):653. J Urol. 1996. PMID: 8558693 Free article. No abstract available.

4

Inhibition of apoptotic proteins causes multidrug resistance in renal carcinoma cells.

Scheltema JM, Romijn JC, van Steenbrugge GJ, Schröder FH, Mickisch GH. Scheltema JM, et al. Among authors: schroder fh. Anticancer Res. 2001 Sep-Oct;21(5):3161-6. Anticancer Res. 2001. PMID: 11848468

5

Peyronie's disease and congenital penile curvature: long-term results of operative treatment with the plication procedure.

Nooter RI, Bosch JL, Schröder FH. Nooter RI, et al. Among authors: schroder fh. Br J Urol. 1994 Oct;74(4):497-500. doi: 10.1111/j.1464-410x.1994.tb00430.x. Br J Urol. 1994. PMID: 7820430

6

Orbital tumours as a first indication of urological malignancies.

Weijerman PC, Boeve ER, Mickisch GH, Simonsz HJ, Schroder FH. Weijerman PC, et al. Among authors: schroder fh. Br J Urol. 1997 Feb;79(2):288-9. doi: 10.1046/j.1464-410x.1997.08027.x. Br J Urol. 1997. PMID: 9052487 No abstract available.

7

Decreased levels of topoisomerase II alpha in human renal cell carcinoma lines resistant to etoposide.

Scheltema JM, Romijn JC, van Steenbrugge GJ, Beck WT, Schröder FH, Mickisch GH. Scheltema JM, et al. Among authors: schroder fh. J Cancer Res Clin Oncol. 1997;123(10):546-54. doi: 10.1007/s004320050103. J Cancer Res Clin Oncol. 1997. PMID: 9393588

8

Chemosensitivity of prostate cancer cell lines and expression of multidrug resistance-related proteins.

van Brussel JP, van Steenbrugge GJ, Romijn JC, Schröder FH, Mickisch GH. van Brussel JP, et al. Among authors: schroder fh. Eur J Cancer. 1999 Apr;35(4):664-71. doi: 10.1016/s0959-8049(98)00435-3. Eur J Cancer. 1999. PMID: 10492644

9

A phase II study of temozolomide in hormone-refractory prostate cancer.

van Brussel JP, Busstra MB, Lang MS, Catsburg T, Schröder FH, Mickisch GH. van Brussel JP, et al. Among authors: schroder fh. Cancer Chemother Pharmacol. 2000;45(6):509-12. doi: 10.1007/s002800051027. Cancer Chemother Pharmacol. 2000. PMID: 10854140 Clinical Trial.

10

Expression of multidrug resistance related proteins and proliferative activity is increased in advanced clinical prostate cancer.

Van Brussel JP, Jan Van Steenbrugge G, Van Krimpen C, Bogdanowicz JF, Van Der Kwast TH, Schröder FH, Mickisch GH. Van Brussel JP, et al. Among authors: schroder fh. J Urol. 2001 Jan;165(1):130-5. doi: 10.1097/00005392-200101000-00032. J Urol. 2001. PMID: 11125381

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

606 results

Search Page

Filters